CDKN2A and cervicitis: As the current ‘gold‐standard’ biomarker for detection of HPV‐related cervical disease at the protein level [25, 26] and a target which has been shown to be upregulated at the mRNA level over different stages of cervical disease [22, 27], p16 was a suitable target gene to investigate.